National Comprehensive Cancer Network

About NCCN

Free Patient Resource Available for Multiple Myeloma on

By Lacey Marlow, Associate Medical Writer

The NCCN Guidelines for Patients®: Multiple Myeloma, Version 1.2014, is now available to download for free on This NCCN Guidelines for Patients® is a high-quality resource for patients and caregivers in the process of planning or receiving treatment. It includes the most recent test and treatment recommendations for Multiple Myeloma.

The National Comprehensive Cancer Network® (NCCN®) aims to provide people with cancer and the general public with state-of-the-art cancer treatment information in easy-to-understand language. The NCCN Guidelines for Patients, translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), are meant to help patients with cancer talk to their doctors about the best treatment options for the type of cancer they have.

The NCCN Guidelines for Patients®: Multiple Myeloma was developed according to plain language principles to improve health literacy. The design and format feature patient-friendly elements such as medical illustrations alongside descriptions of body parts, tests, and treatments. It also includes an expansive glossary with definitions of medical terms and acronyms.

The 2014 update includes important changes to recommended systemic therapy options and combinations in the treatment guide. The combination of carfilzomib, lenalidomide, and dexamethasone has been added as a primary treatment option for patients who will receive a stem cell transplant. Two newly added maintenance treatment options include bortezomib + prednisone and bortezomib + thalidomide. Pomalidomide (Pomalyst), a recently approved immunomodulator, is now recommended as an option for additional treatment after previous treatments have failed.

NCCN currently offers NCCN Guidelines for Patients for the following: Breast, Colon, Esophageal, Non-Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers, Chronic Myelogenous Leukemia, Lung Cancer Screening, Malignant Pleural Mesothelioma, Melanoma, Multiple Myeloma, and Caring for Adolescents and Young Adults (AYA).

Funding for the NCCN Guidelines for Patients is made possible through the NCCN Foundation®.

To view the NCCN Guidelines for Patients: Multiple Myeloma, visit